Skip to main content
Log in

Determination of clindamycin and its metabolite clindamycin sulfoxide in diverse sewage samples

  • 14th EuCheMS International Conference on Chemistry and the Environment (ICCE 2013, Barcelona, June 25 - 28, 2013)
  • Published:
Environmental Science and Pollution Research Aims and scope Submit manuscript

Abstract

In a research project on risk management of harmful substances in water cycles, clindamycin and 12 further antibiotics were determined in different sewage samples. In contrast to other antibiotics, an increase of the clindamycin concentration in the final effluent in comparison to the influent of the sewage treatment plant (STP) was observed. A back transformation from the main metabolite clindamycin sulfoxide to clindamycin during the denitrification process has been discussed. Therefore, the concentration of this metabolite was measured additionally. Clindamycin sulfoxide was stable in the STP and the assumption of back transformation of the metabolite to clindamycin was confuted. To explain the increasing clindamycin concentration in the STP, the ratio of clindamycin sulfoxide to clindamycin was observed. The ratio increased in dry spells with concentrated samples and with long dwell time in the sewer system. A short hydraulic retention in waste water system and diluted samples in periods of extreme rainfall lead to a lower ratio of clindamycin sulfoxide to clindamycin concentration. A plausible explanation of this behavior could be that clindamycin was adsorbed strongly to a component of the sewage during this long residence time and in the STP, clindamycin was released. In the common sample preparation in the lab, clindamycin was not released. Measurements of clindamycin and clindamycin sulfoxide in the influent and effluent of STP is advised for sewage monitoring.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Batt AL, Bruce IB, Aga DS (2006) Evaluating the vulnerability of surface waters to antibiotic contamination from varying wastewater treatment plant discharges. Environ Pollut 142:295–302

    Article  CAS  Google Scholar 

  • Brooks BW, Huggett DBE (2012) Human pharmaceuticals in the environment: current and future perspectives. emerging topics in ecotoxicology—principles, approaches and perspectives, 4. Springer Sciences + Business Media, New York

    Book  Google Scholar 

  • Kovalova L, Siegrist H, Singer H, Wittmer A, McArdell CS (2012) Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ Sci Technol 46:1536–1545

    Article  CAS  Google Scholar 

  • Kummerer K (2009a) The presence of pharmaceuticals in the environment due to human use—present knowledge and future challenges. J Environ Manage 90:2354–2366

    Article  Google Scholar 

  • Kummerer K (2009b) Antibiotics in the aquatic environment—a review—part I. Chemosphere 75:417–434

    Article  Google Scholar 

  • Langford KH, Thomas KV (2009) Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ Int 35:766–770

    Article  CAS  Google Scholar 

  • Schubert S, Rossmann J, Oertel R, Kirch W (in prep.): Simultaneous determination of most prescribed antibiotics in multiple wastewater by SPE-LC-MS/MS

  • Schubert S, Mühlbauer V, Oertel R, Knoth H, Kirch W (submitted): Risk potential of the most widely prescribed antibiotics in the hospital wastewater

  • Schwabe U, Paffrath D (2011) Arzneiverordnungs-Report 2011. Springer Medizin Verlag, Berlin, Heidelberg

    Book  Google Scholar 

  • Spongberg AL, Witter JD (2008) Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Sci Total Environ 397:148–157

    Article  CAS  Google Scholar 

  • Stackelberg PE, Gibs J, Furlong ET, Meyer MT, Zaugg SD, Lippincott RL (2007) Efficiency of conventional drinking-water-treatment processes in removal of pharmaceuticals and other organic compounds. Sci Total Environ 377:255–272

    Article  CAS  Google Scholar 

  • Verlicchi P, Al Aukidy M, Galletti A, Petrovic M, Barcelo D (2012) Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci Total Environ 430:109–118

    Article  CAS  Google Scholar 

  • Wynalda MA, Hutzler JM, Koets MD, Podoll T, Wienkers LC (2003) In vitro metabolism of clindamycin in human liver and intestinal microsomes. Drug Metab Dispos 31:878–887

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The project ANTI-Resist (02WRS1272A) is funded by the German Federal Ministry of Education and Research within the initiative Risk Management of Emerging Compounds and Pathogens in the Water Cycle (RISKWa).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reinhard Oertel.

Additional information

Responsible editor: Hongwen Sun

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oertel, R., Schubert, S., Mühlbauer, V. et al. Determination of clindamycin and its metabolite clindamycin sulfoxide in diverse sewage samples. Environ Sci Pollut Res 21, 11764–11769 (2014). https://doi.org/10.1007/s11356-013-2333-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11356-013-2333-2

Keywords

Navigation